Moving towards a local testing solution for undetermined thyroid fine-needle aspirates: validation of a novel custom DNA-based NGS panel.
Roberta SgarigliaMariantonia NacchioIlaria MigliaticoElena VigliarUmberto MalapellePasquale PisapiaCaterina De LucaAntonino IaccarinoDomenico SalvatoreStefania MasoneGiancarlo TronconeClaudio BellevicinePublished in: Journal of clinical pathology (2021)
Our comparative analysis indicates that Nexthyro is a reliable NGS panel. The study also implies that a custom-based solution for routine thyroid FNA is sustainable at the local level, allowing patients with undetermined thyroid nodules affordable access to NGS.